Session 3: Radiotherapy/pharmacy
๐
Article
๐
2005
๐
John Wiley and Sons
๐
French
โ 254 KB
Gastrin releasing peptides (GRP) have been shown to be over expressed in small cell lung, prostate, breast, and pancreatic cancers. Of these pancreatic cancer is of great interest for targeting due to its low survival rate. It is estimated that there will be 31,800 deaths due to pancreatic cancer in